CRISPR Therapeutics AG drawdown: 76.6% below the all-time high (price)
CRISPR Therapeutics AG is 76.6% below its all-time high, set Jan 14, 2021 (as of market close, Oct 16, 2026), measured on price alone — dividends are not included, the convention headlines and crash histories use. The chart shows every day as a percentage of the highest level reached up to that point: 100% means a fresh record, everything below is a drawdown.
- Below all-time high
- −76.6%
- 23.4% of ATH
- All-time high
- $210.04
- Jan 14, 2021
- Time below the high
- 5.8 yrs
- since Jan 14, 2021
- Worst-ever drawdown
- −85.1%
- Apr 8, 2025
- Longest underwater
- 5.8 yrs
- between all-time highs
- Today's level first reached
- Mar 2, 2018
- 8.6 yrs ago
- Last time this deep
- never before
- no prior −76.6% episode
% of all-time high since 2016: price#
The classic underwater chart (drawdown curve), drawn as % of the all-time high — 100% is a fresh record, everything below it is time spent underwater. Basis and range are in the URL, so a particular view is a link.
The deepest drawdowns on record#
Every decline of 15% or more from an all-time high (price basis), deepest first.
| Peak | Trough | Depth | Peak → trough | Recovered by | Underwater |
|---|---|---|---|---|---|
| Jan 14, 2021 | Apr 8, 2025 | −85.1% | 4.2 yrs | not yet | 5.8 yrs+ |
| May 30, 2018 | Dec 21, 2018 | −69.1% | 7 mo | Jun 23, 2020 | 2.1 yrs |
| Feb 28, 2017 | May 31, 2017 | −42.6% | 3 mo | Jan 2, 2018 | 10 mo |
| Jan 4, 2017 | Feb 9, 2017 | −37.2% | 36 days | Feb 28, 2017 | 55 days |
| Mar 14, 2018 | Apr 3, 2018 | −26.7% | 20 days | May 17, 2018 | 2 mo |
| Oct 16, 2020 | Nov 2, 2020 | −21.6% | 17 days | Nov 23, 2020 | 38 days |
| Jan 29, 2018 | Feb 9, 2018 | −21.4% | 11 days | Feb 26, 2018 | 28 days |
| Aug 19, 2020 | Oct 2, 2020 | −20.8% | 44 days | Oct 13, 2020 | 55 days |
Price basis (no dividends) — the convention crash histories use. With dividends reinvested, recoveries arrive years earlier; switch the basis on the chart above to see it.
Drawdown vs what came next#
One dot per month since 2016: how far CRISPR Therapeutics AG stood below its all-time high, and the total return over the following 1, 5 and 10 years.
Read this with survivorship bias in mind: a single asset's history is one surviving sample, so past recoveries here say little about the odds ahead. Monthly windows also overlap heavily (they are not independent samples). Not investment advice.
FAQ#
- How far is CRISPR Therapeutics AG from its all-time high?
- CRISPR Therapeutics AG is currently 76.6% below its all-time high, set Jan 14, 2021 (as of market close, Oct 16, 2026). Prices only, the convention headlines use; with dividends reinvested the gap is usually smaller.
- What was the biggest CRISPR Therapeutics AG drawdown ever?
- The deepest decline on record in our data (since 2016) took CRISPR Therapeutics AG 85.1% below its prior high, bottoming Apr 8, 2025. The table on this page lists every major episode with its peak, trough and recovery date.
Methodology & related#
Daily data since -1 from CRSP; no free deep history exists for CRISPR Therapeutics AG — for a 150-year drawdown record see the S&P 500 drawdown page. The price basis excludes dividends; the total-return basis reinvests them; the real basis additionally deflates by CPI. See also returns by year. Past performance does not predict future returns; not investment advice.